PubMed:20711231 / 1422-1586 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T9","span":{"begin":0,"end":164},"obj":"DRI_Outcome"}],"text":"Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T11","span":{"begin":25,"end":38},"obj":"HP_0003002"},{"id":"T12","span":{"begin":25,"end":38},"obj":"HP_0100013"},{"id":"T13","span":{"begin":32,"end":38},"obj":"HP_0002664"},{"id":"T14","span":{"begin":96,"end":101},"obj":"HP_0002664"}],"text":"Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"20711231-7#9#14#gene2064","span":{"begin":9,"end":14},"obj":"gene2064"},{"id":"20711231-7#25#38#diseaseC0678222","span":{"begin":25,"end":38},"obj":"diseaseC0678222"}],"relations":[{"id":"9#14#gene206425#38#diseaseC0678222","pred":"associated_with","subj":"20711231-7#9#14#gene2064","obj":"20711231-7#25#38#diseaseC0678222"}],"text":"Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo."}

    CoMAGC

    {"project":"CoMAGC","denotations":[{"id":"T1","span":{"begin":142,"end":145},"obj":"Gene"},{"id":"E2","span":{"begin":116,"end":130},"obj":"Negative_regulation"},{"id":"T2","span":{"begin":25,"end":38},"obj":"breast cancer"}],"relations":[{"id":"R1","pred":"themeOf","subj":"T1","obj":"E2"},{"id":"R3","pred":"CGE-decreased","subj":"T1","obj":"T2"},{"id":"R4","pred":"CCS-cancerTOnormal","subj":"T1","obj":"T2"},{"id":"R5","pred":"PT-observation","subj":"T1","obj":"T2"},{"id":"R3","pred":"IGE-unidentifiable","subj":"T1","obj":"T2"}],"text":"Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo."}